Infectious Disease Therapeutics Market To Reach $115.2 Billion By 2030

Infectious Disease Therapeutics Market Growth & Trends

The global infectious disease therapeutics market size is expected to reach USD 115.2 billion by 2030, registering a CAGR of 7.1% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is primarily driven by increasing number of Human Immunodeficiency Virus (HIV), Human Papillomavirus (HPV), TB, and hepatitis cases globally.

Government and private organizations are investing heavily in the healthcare sector to prevent, diagnose, and treat infectious diseases; rising investments for development of new drugs to treat infectious diseases, and increasing number of initiatives for creating awareness about these conditions are expected to boost the market during the forecast period. Furthermore, increasing number of patent expirations and entry of generic drugs in the market are expected to increase the demand for infectious disease therapeutics due to their low prices.

In addition, availability of reimbursement for diagnosis & treatment of these infections and free distribution of drugs by manufacturers in regions with high incidence of these diseases are factors further expected to propel the market growth. However, low penetration rate of anti-infective and availability of large number of counterfeit drugs are expected to restraint the market growth during the forecast period.

North American market held the largest share in 2016. Presence of large number of manufacturers, favorable reimbursement scenario, and increasing healthcare expenditure are major factors responsible for the largest share held by this region. However, Asia Pacific is likely to grow at the highest rate between 2017 and 2025. High prevalence of infectious diseases; improving economic conditions in Asian countries, rising government initiatives to increase the adoption of treatments for infectious diseases, and rising funding activities are factors that can be attributed for the highest growth rate of this region during the forecast period.

 Request a free sample copy or view report summary: Infectious Disease Therapeutics Market Report

Infectious Disease Therapeutics Market Report Highlights

• The HIV segment held the largest revenue share of 31.6% in 2022. The increasing prevalence of HIV, rising funding activities for patients who have HIV, increasing supply of free HIV self-test kits in African countries, and raising awareness campaigns around the globe are the key factors responsible for the largest share held by this segment.

• The HPV segment is expected to grow at the fastest CAGR of 8.1% during the forecast period. Major factors that are responsible for its growth include the increasing prevalence of HPV and the low cost of drugs that are used in the treatment of this infection.

• The hospital's segment held the largest revenue share of 54.5% in 2022. The increasing number of emergency hospital visits reporting infectious diseases is a significant growth factor for the market.

• North America dominated the market with the largest revenue share of 39.9% in 2022. The increasing prevalence of such disorders and favorable reimbursement scenarios are key factors likely to propel the region's demand for infectious disease therapeutics. 

Infectious Disease Therapeutics Market Segmentation

Grand View Research has segmented the global infectious disease therapeutics market on the basis of disease type, end-use, and region:

Infectious Disease Therapeutics Disease Type Outlook (Revenue, USD Billion. 2018 - 2030)

• HIV

• Hepatitis

• Influenza

• TB

• Malaria

• HPV

Infectious Disease Therapeutics End-use Outlook (Revenue, USD Billion, 2018 - 2030)

• Hospitals

• Clinics

• Others

Infectious Disease Therapeutics Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East and Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Infectious Disease Therapeutics Market

• Novartis AG,

• Gilead

• GlaxoSmithKline plc

• Janssen Pharmaceutical, Inc.

• F. Hoffmann-La Roche Ltd.

• BioCryst Pharmaceuticals Inc.

• Merck & Co., Inc.

• Boehringer Ingelheim GmbH.